$23.82
-0.53-2.18%
At close: -
$23.94
0.120.50%
After Hours: Jul 11, 4:01 PM EDT
Comments
Loading...
Latest Vera Therapeutics Stock News | NASDAQ:VERA | Benzinga
Get the latest news on Vera Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Vera Therapeutics performance
Categories: All
Thursday, June 12, 2025
Friday, June 06, 2025
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Crude Oil Gains 2%; ABM Industries Shares Plunge After Q2 Results
- Dow Jumps Over 500 Points; Nonfarm Payrolls Top Estimates
- Lululemon Cuts Earnings Forecast, Joins DocuSign, Samsara And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Tuesday, June 03, 2025
Monday, June 02, 2025
- Scotiabank Maintains Sector Outperform on Ver...
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May
- Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday
- Kidney Health-Focused Vera Therapeutics Stock Price Spikes On Heels Of Successful Trial Data
- HC Wainwright & Co. Maintains Buy on Vera The...
- Vera Therapeutics shares are trading higher a...
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
- Vera Therapeutics Says Atacicept ORIGIN Phase...
Tuesday, May 27, 2025
Wednesday, May 07, 2025
Tuesday, May 06, 2025
Monday, May 05, 2025
Wednesday, April 09, 2025
Thursday, April 03, 2025
Tuesday, March 04, 2025
Thursday, February 27, 2025
Wednesday, February 26, 2025
Tuesday, February 04, 2025
Wednesday, January 22, 2025
Monday, January 13, 2025
Thursday, November 21, 2024
Friday, November 08, 2024
Thursday, November 07, 2024
Tuesday, November 05, 2024
Wednesday, October 30, 2024
Tuesday, October 29, 2024
Monday, October 28, 2024
- Vera Therapeutics Plans To Commence Public Of...
- Guggenheim Maintains Buy on Vera Therapeutics...
- Vera Therapeutics' Atacicept Shows Sustained, Substantial Improvement In Kidney Function For Patients At Almost Two Years
- PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
- Vera Therapeutics shares are trading higher a...
- Reported Saturday, Vera Therapeutics Reveals ...
